Yuuki Ohara

1.4k total citations
24 papers, 396 citations indexed

About

Yuuki Ohara is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Yuuki Ohara has authored 24 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Yuuki Ohara's work include Pancreatic and Hepatic Oncology Research (8 papers), Occupational and environmental lung diseases (6 papers) and Biomarkers in Disease Mechanisms (3 papers). Yuuki Ohara is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Occupational and environmental lung diseases (6 papers) and Biomarkers in Disease Mechanisms (3 papers). Yuuki Ohara collaborates with scholars based in Japan, United States and Germany. Yuuki Ohara's co-authors include Shinya Toyokuni, S. Perwez Hussain, Kyoko Yamashita, Fumiya Ito, Masato Sugano, Masahiro Takeuchi, Yosuke Togashi, Hirohisa Nakamae, Junichiro Yuda and Joji Nagasaki and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Cancer and Pharmacology & Therapeutics.

In The Last Decade

Yuuki Ohara

23 papers receiving 396 citations

Peers

Yuuki Ohara

ONCOL

PRM

IMMUN

D-A Silasi United States

Monique Melis Netherlands

Atsushi Mitsuhashi Japan

Yaqun Li China

Corey Carter United States

Jadzia Tin-Tsen Chou Poland

László Márkász Sweden

Haining Li China

D-A Silasi United States

Yuuki Ohara

168 ×1.0

ONCOL

147 ×1.1

50 ×0.4

PRM

140 ×1.3

IMMUN

87 ×1.3

Citations per year, relative to Yuuki Ohara Yuuki Ohara (= 1×) peers D-A Silasi

Countries citing papers authored by Yuuki Ohara

Since Specialization

Citations

This map shows the geographic impact of Yuuki Ohara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuuki Ohara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuuki Ohara more than expected).

Fields of papers citing papers by Yuuki Ohara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuuki Ohara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuuki Ohara. The network helps show where Yuuki Ohara may publish in the future.

Co-authorship network of co-authors of Yuuki Ohara

This figure shows the co-authorship network connecting the top 25 collaborators of Yuuki Ohara. A scholar is included among the top collaborators of Yuuki Ohara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuuki Ohara. Yuuki Ohara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohara, Yuuki, et al.. (2025). Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Insights into tumor heterogeneity and clinical implications. Pharmacology & Therapeutics. 277. 108946–108946.

Ohara, Yuuki, Amanda J. Craig, Huaitian Liu, et al.. (2024). LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism. Carcinogenesis. 45(7). 475–486. 4 indexed citations

Ohara, Yuuki, Huaitian Liu, Amanda J. Craig, et al.. (2024). ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer. International Journal of Cancer. 155(3). 569–581. 4 indexed citations

Tang, Wei, Azadeh Azizian, Jochen Gaedcke, et al.. (2024). MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways. Carcinogenesis. 45(8). 582–594. 7 indexed citations

Ohara, Yuuki, Amanda J. Craig, Tiffany H. Dorsey, et al.. (2024). ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. Carcinogenesis. 45(11). 845–856. 5 indexed citations

Panigrahi, Gatikrushna, Julián Candia, Tiffany H. Dorsey, et al.. (2023). Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency. JCI Insight. 8(23). 8 indexed citations

Ohara, Yuuki, Wei Tang, Huaitian Liu, et al.. (2023). SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer. Cell Reports. 42(12). 113434–113434. 21 indexed citations

Ohara, Yuuki, et al.. (2022). The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer. Trends in cancer. 8(7). 556–569. 26 indexed citations

Suzuki, Ayako, Takeshi Kuwata, Hiroko Hashimoto, et al.. (2021). Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy. Gastric Cancer. 24(4). 810–822. 10 indexed citations

10.

Ohara, Yuuki, Atsushi Enomoto, Kotaro Sato, et al.. (2020). Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma. Oncology Reports. 44(3). 838–848. 23 indexed citations

11.

Nagasaki, Joji, Yosuke Togashi, Makiko Itami, et al.. (2020). The critical role of CD4+ T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma. Blood Advances. 4(17). 4069–4082. 83 indexed citations

12.

Suzuki, Jun, Motohiro Kojima, Keiju Aokage, et al.. (2019). Clinicopathological characteristics associated with necrosis in pulmonary metastases from colorectal cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 474(5). 569–575. 8 indexed citations

13.

Sato, Kotaro, Lei Shi, Fumiya Ito, et al.. (2019). Non-thermal plasma specifically kills oral squamous cell carcinoma cells in a catalytic Fe(II)-dependent manner. Journal of Clinical Biochemistry and Nutrition. 65(1). 8–15. 43 indexed citations

14.

Ohara, Yuuki, Takahiko Ito, Makoto Ito, Kyoko Yamashita, & Shinya Toyokuni. (2018). Acute fulminant invasive pulmonary aspergillosis in an immunocompetent host: An autopsy case report. Medical Mycology Case Reports. 20. 39–42. 2 indexed citations

15.

Ohara, Yuuki, Shan Hwu Chew, Nobuaki Misawa, et al.. (2018). Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model. Oncotarget. 9(26). 18494–18509. 33 indexed citations

16.

Ohara, Yuuki, Seiichi Kato, Daisuke Yamashita, et al.. (2018). An autopsy case report: Differences in radiological images correlate with histology in Erdheim–Chester disease. Pathology International. 68(6). 374–381. 4 indexed citations

17.

Chew, Shan Hwu, Yasumasa Okazaki, Shinya Akatsuka, et al.. (2017). Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma. Free Radical Biology and Medicine. 106. 91–99. 20 indexed citations

18.

Ohara, Yuuki, et al.. (2017). Phlebotomy as a preventive measure for crocidolite‐induced mesothelioma in male rats. Cancer Science. 109(2). 330–339. 25 indexed citations

19.

Ichimaru, Tomohiro, et al.. (1993). Treatment of severe pertussis by administration of specific gamma globulin with high titers anti‐toxin antibody. Acta Paediatrica. 82(s385). 1076–1078. 6 indexed citations

20.

Ohara, Yuuki, et al.. (1993). ANTI-VERY LATE ANTIGEN-4 ANTIBODY SUPPRESSES ACUTE ACTIVE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN LEWIS RATS. Journal of Neuropathology & Experimental Neurology. 52(3). 310–310. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact